eMedevents
  • 141,592+ Medical Conferences
  • 273 Specialties
  • 10,680 Organizers
  • 153,448 Speakers
  • 156 Countries
  • 4,613 Cities
47,197+
CME Conference Registrations Sold
Home  >  Speakers  >  Christopher Haqq
Christopher Haqq

Christopher Haqq

    BS, MD, PhD
Executive Vice President, Chief Scientific Officer | Westlake Village, California    United States of America
Biotechnology, Research And Clinical Research
Biotechnology, Research And Development,...More
Spoken at 2 events

Biography :

Dr. Christopher Haqq is the EVP, Chief Scientific Officer, and joined Atara Biotherapeutics in September 2012. He brings 20 years of clinical, academic and drug development experience from biopharma companies large and small. He was recently Vice President for Clinical Research and Development at Cougar Biotechnology and Johnson & Johnson’s Janssen, where he was the lead clinician for a pivotal prostate cancer study leading to market approval for Zytiga® (abiraterone acetate). Previously at Amgen, he led early development studies of the anti-insulin like growth factor type 1 receptor AMG 479 (ganitumab) antibody. He has served as medical monitor for more than 10 clinical trials and has contributed to drug development programs for a wide range of molecules.

Chris has worked closely with the European Medicines Agency, the U.S. Food and Drug Administration and other global regulatory agencies–filing IND applications, new drug applications, special protocol assessments and their international equivalents. Earlier in his career, Chris practiced as a medical oncologist and led a translational science laboratory as an Assistant Adjunct Professor in the Division of Hematology/Oncology at the University of California, San Francisco. In his post-graduate training, also at UCSF, he served as an Intern and Resident in Internal Medicine, Fellow in Medical Oncology and Fellow in Molecular Medicine. Chris completed his M.D. and Ph.D. at Harvard Medical School and his B.S. at Stanford University. He is board certified in Medical Oncology and Internal Medicine.

**********************
***** ********
 
For speaker's contact information - Contact us

Specialties

Biotechnology, Research and Clinical Research

Interested Topics

Biotechnology, Research and Development, Clinical Research, Oncology, Clinical Trials, Clinical Development, Drug Development, Drug Discovery, Molecular Biology, Internal Medicine

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message